Polaris Pharmaceuticals Adopts Medidata Payments

Published on: September 20, 2016

Medidata has announced that Polaris Pharmaceuticals has selected Medidata Payments to integrate its clinical trial site reimbursement process.

Medidata has announced that Polaris Pharmaceuticals has selected Medidata Payments to integrate its clinical trial site reimbursement process. Medidata Payments has the ability to pay clinical research sites worldwide and for use across hundreds of studies.

Read the full release here